Oncogene - Table of Contents alert Volume 31 Issue 50

TABLE OF CONTENTS Volume 31, Issue 50 (December 2012) In this issue Original Articles Short Communication Also new AOP Advertisement The POWER of ChIP-seq using just 10,000 cells Diagenode’s new powerful True MicroChIP and Microplex kits now facilitate robust ChIP-seq from truly small inputs: Revolutionary: Highly efficient ChIP recovery and enrichment from ONLY 10,000 cells Reliable and accurate sequencing library preparation from picogram inputs Learn more. Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement New Year! New journal for your research! Celebrate with 50% off the article processing charge Submit your research to Blood Cancer Journal between January and March 2013 and receive 50% off the article processing charge. This offer is for a limited time only. Spread the word. Indexed by PubMed and Thomson Reuters. Submit your research today and quote discount code BCJ_50APC13 (Offer expires 31st March 2013)   Original Articles Top CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-β signaling J M Kang, S Park, S J Kim, H Y Hong, J Jeong, H-S Kim and S-J Kim Oncogene 2012 31: 5123-5131; advance online publication, February 6, 2012; 10.1038/onc.2012.18 Abstract | Full Text EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase S D Wang, P Rath, B Lal, J-P Richard, Y Li, C R Goodwin, J Laterra and S Xia Oncogene 2012 31: 5132-5143; advance online publication, February 6, 2012; 10.1038/onc.2012.16 Abstract | Full Text A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1 S M Cork, B Kaur, N S Devi, L Cooper, J H Saltz, E M Sandberg, S Kaluz and E G Van Meir Oncogene 2012 31: 5144-5152; advance online publication, February 13, 2012; 10.1038/onc.2012.1 Abstract | Full Text BAG3 controls angiogenesis through regulation of ERK phosphorylation A Falco, M Festa, A Basile, A Rosati, M Pascale, F Florenzano, S L Nori, V Nicolin, M Di Benedetto, M L Vecchione, C Arra, A Barbieri, V De Laurenzi and M C Turco Oncogene 2012 31: 5153-5161; advance online publication, February 6, 2012; 10.1038/onc.2012.17 Abstract | Full Text The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer A L Smith, R Iwanaga, D J Drasin, D S Micalizzi, R L Vartuli, A-C Tan and H L Ford Oncogene 2012 31: 5162-5171; advance online publication, January 30, 2012; 10.1038/onc.2012.11 Abstract | Full Text 5-Aza-2′-deoxycytidine-induced genome rearrangements are mediated by DNMT1 A Y Maslov, M Lee, M Gundry, S Gravina, N Strogonova, C Tazearslan, A Bendebury, Y Suh and J Vijg Oncogene 2012 31: 5172-5179; advance online publication, February 20, 2012; 10.1038/onc.2012.9 Abstract | Full Text Cyclin E drives human keratinocyte growth into differentiation A Freije, L Ceballos, M Coisy, L Barnes, M Rosa, E De Diego, J M Blanchard and A Gandarillas Oncogene 2012 31: 5180-5192; advance online publication, February 20, 2012; 10.1038/onc.2012.22 Abstract | Full Text Short Communication Top Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells C Schönherr, K Ruuth, S Kamaraj, C-L Wang, H-L Yang, V Combaret, A Djos, T Martinsson, J G Christensen, R H Palmer and B Hallberg Oncogene 2012 31: 5193-5200; advance online publication, January 30, 2012; 10.1038/onc.2012.12 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.